$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023039843 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$414.1K	$515.2K	$510.7K
YoY Change	-23.38%	0.88%	228.11%
Cost Of Revenue	$209.1K	$245.4K	$249.6K
YoY Change	-0.3%	-1.71%	695.51%
Gross Profit	$205.0K	$269.9K	$261.1K
YoY Change	-38.01%	3.36%	110.09%
Gross Profit Margin	49.51%	52.38%	51.12%
Selling, General & Admin	$768.9K	$785.2K	$1.925M
YoY Change	5.04%	-59.2%	-61.25%
% of Gross Profit	375.12%	290.98%	737.15%
Research & Development		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit		0.0%	0.0%
Depreciation & Amortization	$20.55K	$20.85K	$22.91K
YoY Change	-9.71%	-8.99%	827.53%
% of Gross Profit	10.02%	7.73%	8.78%
Operating Expenses	$776.8K	$793.5K	$1.935M
YoY Change	4.67%	-58.99%	-61.07%
Operating Profit	$3.480M	-$523.6K	-$1.674M
YoY Change	-945.66%	-68.72%	-65.46%
Interest Expense	$166.2K	$195.8K	-$248.6K
YoY Change	-54.13%	-178.76%	1252.45%
% of Operating Profit	4.78%
Other Income/Expense, Net	$294.4K	-$199.5K
YoY Change
Pretax Income	$3.774M	-$723.1K	-$1.919M
YoY Change	-473.93%	-62.33%	-60.54%
Income Tax
% Of Pretax Income
Net Earnings	$3.774M	-$723.1K	-$1.919M
YoY Change	-473.93%	-62.33%	-60.54%
Net Earnings / Revenue	911.54%	-140.35%	-375.83%
Basic Earnings Per Share	$0.01	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$6.717K
COMMON SHARES
Basic Shares Outstanding	505.0M shares	447.7M shares	283.8M shares
Diluted Shares Outstanding	2.349B shares	425.0M shares	283.8M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.512M	$82.98K	$170.1K
YoY Change	518.09%	-51.22%	5.88%
Cash & Equivalents	$1.512M	$82.98K	$170.1K
Short-Term Investments
Other Short-Term Assets	$66.95K	$88.85K	$39.62K
YoY Change	-38.77%	124.26%	-47.62%
Inventory	$119.1K	$59.35K	$63.08K
Prepaid Expenses	$16.95K
Receivables	$133.3K	$198.7K	$310.4K
Other Receivables	$0.00	$0.00	$3.750K
Total Short-Term Assets	$1.831M	$429.9K	$587.0K
YoY Change	174.75%	-26.76%	49.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.05K	$88.08K	$389.5K
YoY Change	-31.03%	-77.39%	1455.01%
Goodwill	$350.5K	$350.5K
YoY Change	0.0%
Intangibles	$254.7K	$267.3K
YoY Change	-16.55%
Long-Term Investments	$0.00	$7.780K	$6.480K
YoY Change	-100.0%	20.06%	-9.12%
Other Assets
YoY Change
Total Long-Term Assets	$870.8K	$1.060M	$1.064M
YoY Change	-27.9%	-0.37%	3207.3%
TOTAL ASSETS
Total Short-Term Assets	$1.831M	$429.9K	$587.0K
Total Long-Term Assets	$870.8K	$1.060M	$1.064M
Total Assets	$2.702M	$1.490M	$1.651M
YoY Change	44.15%	-9.75%	288.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$729.7K	$828.5K	$853.3K
YoY Change	-12.03%	-2.91%	-7.49%
Accrued Expenses	$390.8K	$859.5K	$937.4K
YoY Change	-23.99%	-8.31%	54.86%
Deferred Revenue
YoY Change
Short-Term Debt	$1.031M	$1.195M	$378.1K
YoY Change	155.22%	215.98%
Long-Term Debt Due	$83.21K	$1.592M	$640.0K
YoY Change	-92.63%	148.78%	16.92%
Total Short-Term Liabilities	$2.907M	$5.020M	$2.855M
YoY Change	-16.01%	75.85%	37.58%
LONG-TERM LIABILITIES
Long-Term Debt	$5.550K	$625.7K	$530.3K
YoY Change	-97.95%	17.99%	5940.21%
Other Long-Term Liabilities	$128.7K	$227.7K	$210.5K
YoY Change	-59.78%	8.16%
Total Long-Term Liabilities	$134.3K	$853.4K	$740.9K
YoY Change	-77.28%	15.19%	8338.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.907M	$5.020M	$2.855M
Total Long-Term Liabilities	$134.3K	$853.4K	$740.9K
Total Liabilities	$3.041M	$5.874M	$3.772M
YoY Change	-24.95%	55.72%	81.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$59.63M	-$63.41M
YoY Change	-1.35%
Common Stock	$523.2K	$447.7K
YoY Change	70.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$454.9K	-$4.518M	-$2.121M
YoY Change
Total Liabilities & Shareholders Equity	$2.702M	$1.490M	$1.651M
YoY Change	44.15%	-9.75%	288.2%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$3.774M	-$723.1K	-$1.919M
YoY Change	-473.93%	-62.33%	-60.54%
Depreciation, Depletion And Amortization	$20.55K	$20.85K	$22.91K
YoY Change	-9.71%	-8.99%	827.53%
Cash From Operating Activities	-$622.0K	-$291.0K	-$503.8K
YoY Change	110.43%	-42.24%	22.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$4.043M
YoY Change
Cash From Investing Activities	$4.043M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.992M	$276.9K	154.0K
YoY Change	-638.34%	79.81%	-38.41%
NET CHANGE
Cash From Operating Activities	-622.0K	-$291.0K	-503.8K
Cash From Investing Activities	4.043M
Cash From Financing Activities	-1.992M	$276.9K	154.0K
Net Change In Cash	1.429M	-$14.11K	-349.8K
YoY Change	1819.05%	-95.97%	114.95%
FREE CASH FLOW
Cash From Operating Activities	-$622.0K	-$291.0K	-$503.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	C-Bond Systems, Inc
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-53029
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6035 South Loop East
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77033
CY2023Q1	dei	City Area Code CityAreaCode	832
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	649-5658
CY2023Q1	dei	Security12b Title Security12bTitle	N/A
CY2023Q1	dei	Trading Symbol TradingSymbol	N/A
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	504976437	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82984	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97091	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	198688	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	59346	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	88850	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71171	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	279	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	429868	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	515429	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	88082	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	346693	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	267292	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q1	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7775	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6482	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1060333	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1108609	usd
CY2023Q1	us-gaap	Assets Assets	1490201	usd
CY2022Q4	us-gaap	Assets Assets	1624038	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1194818	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2023Q1	cbnt	Note Payable Net Of Discount Current Portion NotePayableNetOfDiscountCurrentPortion	1592207	usd
CY2022Q4	cbnt	Note Payable Net Of Discount Current Portion NotePayableNetOfDiscountCurrentPortion	1576438	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	828458	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	779765	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	859517	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736393	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	12493	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	10027	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	402949	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590632	usd
CY2023Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	9382	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	22637	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	120640	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	117671	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5020464	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4864813	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	168500	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	251263	usd
CY2023Q1	cbnt	Note Payable Net Of Current Portion And Discount NotePayableNetOfCurrentPortionAndDiscount	207222	usd
CY2022Q4	cbnt	Note Payable Net Of Current Portion And Discount NotePayableNetOfCurrentPortionAndDiscount	208804	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	250000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	250000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	227702	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	258895	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	853424	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	968962	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5873888	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5833775	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1186719	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1037201	usd
CY2023Q1	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1710500	usd
CY2022Q4	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1803731	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	447704272	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	447704272	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350270172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350270172	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	447704	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	350270	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55550606	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55141503	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63413236	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62693184	usd
CY2023Q1	cbnt	Total C Bond Systems Inc Shareholders Deficit TotalCBondSystemsIncShareholdersDeficit	-7414926	usd
CY2022Q4	cbnt	Total C Bond Systems Inc Shareholders Deficit TotalCBondSystemsIncShareholdersDeficit	-7201411	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	134020	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	150742	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1490201	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1624038	usd
CY2023Q1	us-gaap	Revenues Revenues	515220	usd
CY2022Q1	us-gaap	Revenues Revenues	510709	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	245360	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	249630	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	269860	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	261079	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	12137	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	1014508	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	426872	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1416018	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	187690	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	314212	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	178900	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204613	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	793462	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1934843	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-523602	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1673764	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2925	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	195786	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	248580	usd
CY2023Q1	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	3699	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-199485	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-245655	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919419	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-16722	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-13020	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	13687	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	14005	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-720052	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1920404	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	424991656	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	283833276	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	40000	usd
CY2023Q1	cbnt	Common Shares Issued For Compensation CommonSharesIssuedForCompensation	53000	usd
CY2023Q1	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	101400	usd
CY2023Q1	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-13687	usd
CY2023Q1	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022Q1	cbnt	Common Shares Issued For Accounts Payable CommonSharesIssuedForAccountsPayable	2174	usd
CY2022Q1	cbnt	Common Shares Issued For Compensation CommonSharesIssuedForCompensation	14250	usd
CY2022Q1	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	12000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12963	usd
CY2022Q1	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-14005	usd
CY2022Q1	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	42702	usd
CY2022Q1	cbnt	Beneficial Conversion Charge For Issuance Of Series B Preferred Shares For Accrued Compensation BeneficialConversionChargeForIssuanceOfSeriesBPreferredSharesForAccruedCompensation	957556	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919419	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4870820	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919419	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20850	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22910	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	63916	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	207727	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12137	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1014508	usd
CY2023Q1	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	40667	usd
CY2022Q1	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	111800	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2925	usd
CY2023Q1	cbnt	Increase Decrease In Lease Cost IncreaseDecreaseInLeaseCost	495	usd
CY2022Q1	cbnt	Increase Decrease In Lease Cost IncreaseDecreaseInLeaseCost	-723	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70754	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	134598	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-18100	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19853	usd
CY2023Q1	cbnt	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	-19639	usd
CY2022Q1	cbnt	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	325	usd
CY2023Q1	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	-279	usd
CY2022Q1	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	-80265	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48693	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23816	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	123124	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	25482	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	2466	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	34317	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11583	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-13255	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	35627	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290971	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-503769	usd
CY2023Q1	cbnt	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	275000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	175000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	48136	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	21019	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276864	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	153981	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14107	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-349788	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82984	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170110	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	33795	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4754	usd
CY2023Q1	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	40000	usd
CY2023Q1	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation	78000	usd
CY2023Q1	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	144000	usd
CY2022Q1	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	278654	usd
CY2023Q1	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	13687	usd
CY2022Q1	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	14005	usd
CY2022Q1	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt	12963	usd
CY2023Q1	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	101400	usd
CY2022Q1	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	12000	usd
CY2022Q1	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable	2174	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner, developer, and manufacturer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Additionally, the Company has expanded its product line to include disinfection products. The Company operates in two divisions: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sells a windshield strengthening, water repellent solution called C-Bond nanoShield™ as well as disinfection products. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Shareholder”), and (iii) Michael Wanke as the Representative of the Mobile Shareholder. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Mobile’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Mobile Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Shares. The Mobile Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. Two years after closing, the Company has the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement (the “Additional Closing”). Mobile provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Mobile also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Mobile’s owner-operator, Mr. Wanke, joined the Company as President of its Patriot Glass Solutions division.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 8, 2023, the Company entered into an Asset Purchase Agreement with a third-party entity (the “Buyer”), whereby the Company sold its C-Bond nanoShield product line to the Buyer for cash of $4,000,000. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. The “Assets” shall be comprised of certain intangible assets, intellectual property, work In process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division. Following the Closing, the Parties shall reasonably cooperate to complete a transaction wherein the Company shall assign to Buyer, and Buyer shall take assignment from the Company, the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as to be reasonably agreed to by the parties and the lessor pursuant to the Lease. (See Note 16).</p>
CY2021Q2	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q2	cbnt	Issued And Outstanding Percent IssuedAndOutstandingPercent	0.80	pure
CY2021Q3	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q3	cbnt	Restricted Shares Of Common Stock RestrictedSharesOfCommonStock	28021016	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	800000	usd
CY2021Q3	cbnt	Issued And Outstanding Interest IssuedAndOutstandingInterest	0.20	pure
CY2021Q3	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
CY2023Q2	cbnt	Sales Sales	4000000	usd
CY2021Q3	cbnt	Consolidated Financial Statements Percentage ConsolidatedFinancialStatementsPercentage	0.80	pure
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the three months ended March 31, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26648	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26648	usd
CY2023Q1	cbnt	Beneficial Conversion Feature BeneficialConversionFeature	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Beneficial Conversion Feature</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Convertible debt includes conversion terms that are considered in the money compared to the market price of the stock on the date of the related agreement. The Company calculates the beneficial conversion feature and records a debt discount with the amount being amortized to interest expense over the term of the note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3624	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3121	usd
CY2023Q1	cbnt	Costs Incurred CostsIncurred	0	usd
CY2022Q1	cbnt	Costs Incurred CostsIncurred	0	usd
	cbnt	Research And Development Costs ResearchAndDevelopmentCosts	4155	usd
	cbnt	Research And Development Costs ResearchAndDevelopmentCosts	41818	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1997216731	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	526648041	shares
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	234210	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	304964	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35522	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35522	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	198688	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	111	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1501	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	59235	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	75945	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	59346	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	77446	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	59346	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2022Q3	cbnt	Current Exercise Price CurrentExercisePrice	0.011
CY2022Q3	cbnt	New Exercise Price NewExercisePrice	0.009
CY2023Q1	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12626	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12626	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	175848	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167624	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	88082	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	8224	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	10284	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2023Q1	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
CY2022Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2023Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	85224	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	72598	usd
CY2023Q1	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	267292	usd
CY2022Q4	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	279918	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50503	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15783	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	167292	usd
CY2021Q4	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2021Q4	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05
CY2021Q4	cbnt	Conversion Shares Percent conversionSharesPercent	0.50	pure
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	680000	usd
CY2021Q4	cbnt	Original Issued Discount Rate OriginalIssuedDiscountRate	75000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	60000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	10000	usd
CY2023Q1	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	33000000	shares
CY2022Q2	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2022Q2	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2022-10-15
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0125
CY2022Q2	cbnt	Conversion Price Per Share ConversionPricePerShare	0.00875
CY2022Q4	cbnt	Penalty Amount PenaltyAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	206250	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2022	cbnt	Initial Note InitialNote	1031250	usd
CY2022Q2	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2022Q2	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	33000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q4	cbnt	Aggregate Noncash Debt Discount AggregateNoncashDebtDiscount	680000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	104250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	100000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	64250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	60000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	54250	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	50000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.15	pure
CY2023Q1	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.25	pure
CY2023Q1	cbnt	Conversion Of Percentage ConversionOfPercentage	0.65	pure
CY2022Q4	cbnt	Excess Outstanding Shares Percentage ExcessOutstandingSharesPercentage	0.0499	pure
CY2022Q4	cbnt	Aggregate Debt Premium AggregateDebtPremium	90731	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1593	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	206250	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	134162	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	83138	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1254000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1199750	usd
CY2023Q1	cbnt	Add Put Premium AddPutPremium	119943	usd
CY2022Q4	cbnt	Add Put Premium AddPutPremium	90731	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	10625	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7968	usd
CY2023Q1	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	1363318	usd
CY2022Q4	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	1282513	usd
CY2023Q1	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	1194818	usd
CY2022Q4	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	1031250	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	168500	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	251263	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	1851244	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1899380	usd
CY2023Q1	cbnt	Note Payable Ppp Note NotePayable_PppNote	18823	usd
CY2022Q4	cbnt	Note Payable Ppp Note NotePayable_PppNote	18823	usd
CY2023Q1	cbnt	Total Notes Payable TotalNotesPayable	1870067	usd
CY2022Q4	cbnt	Total Notes Payable TotalNotesPayable	1918203	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	70638	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	132961	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	1799429	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	1785242	usd
CY2023Q1	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-1592207	usd
CY2022Q4	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-1576438	usd
CY2023Q1	cbnt	Notes Payable Longterm NotesPayableLongterm	207222	usd
CY2022Q4	cbnt	Notes Payable Longterm NotesPayableLongterm	208804	usd
CY2018Q4	cbnt	Proceeds From Notes Payables ProceedsFromNotesPayables	400000	usd
CY2018Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
CY2023Q1	cbnt	Loan Agreement Description LoanAgreementDescription	In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018, the Company shall have 45 days (through and until February 15, 2019) to cure such violation and an establish accounts receivable plus inventory equal to the unpaid principal balance of the Note. Commencing March 31, 2019 and at all times thereafter through the remainder of the commitment period and for so long thereafter as there is any amount still due and owing under the Note, the Company must maintain an accounts receivable balances plus inventory such that the outstanding principal borrowed by Company under the Loan Agreement and Note is less than or equal to eighty five percent (85%) of accounts receivable plus fifty percent (50%) of inventory, all as measured at the same point in time.
CY2023Q1	cbnt	Note Balance Due NoteBalanceDue	400000	usd
CY2023Q1	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	309995	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	292241	usd
CY2023Q1	cbnt	Company Agreed CompanyAgreed	200000	usd
CY2022Q4	us-gaap	Shares Issued SharesIssued	22000000	shares
CY2023Q1	cbnt	Principal Amount principalAmount	197500	usd
CY2022Q1	cbnt	Accrued Interest Payables AccruedInterestPayables	6217	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1750000	shares
CY2022Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q2	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q2	us-gaap	Debt Instrument Description DebtInstrumentDescription	GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under this Note at a conversion price of $0.011, subject to adjustment as defined in the GS Capital Note. The Company did not calculate a beneficial conversion feature since the GS Capital Note is contingently convertible upon default on the GS Capital Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The GS Capital Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. Events of default include, amongst other items, failure to pay principal or interest, bankruptcy, delisting of the Company’s stock, financial statement restatements, or if the Company effectuates a reverse split. Upon the occurrence of any event of default, the GS Capital Note shall become immediately and automatically due and payable and the Company shall pay to GS Capital, in full satisfaction of its obligations hereunder, an amount equal to: (a) the then outstanding principal amount of this note plus (b) accrued and unpaid interest on the unpaid principal amount of this note to the date of payment (the “mandatory prepayment date”) plus (y) default interest, if any, multiplied by 120%. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital June 2022 note by 60 days. Specifically, the maturity date of the GS Capital June 2022 note was extended to August 23, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $53,512 of principal balance and during the three months ended March 31, 2023, paid principal balance of $19,592. On March 31, 2023, the principal balance due on the GS Capital Note amounted to $121,896 and accrued interest payable amounted to $10,150. On December 31, 2022, the principal balance due on the GS Capital Note amounted to $141,488 and accrued interest payable amounted to $7,471. In May 2023, the GS Capital June 2022 Note was paid in full (See Note 16).On July 26, 2022, the Company closed a Securities Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. The Company further issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, the Company issued 998,008 of its common stock to the placement agent as fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Additionally, the GS Capital July 2022 Note is convertible upon an event of default into common shares at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary following the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the GS Capital July 2022 Note at a conversion price of $0.011, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the July 2022 Note. As of December 31, 2022, the Company is not in default on this note.
CY2022Q4	cbnt	Company Paid CompanyPaid	53512	usd
CY2023Q1	cbnt	Company Paid CompanyPaid	19592	usd
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2600000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	998008	shares
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34606	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q3	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The July 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.
CY2022	cbnt	Paid Principal PaidPrincipal	34120	usd
CY2023Q1	cbnt	Paid Principal PaidPrincipal	19391	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	160880	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6441	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3300000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	773626	shares
CY2023Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Additionally, the September 2022 Note is convertible into common shares upon an event of default at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September 2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the September 2022 Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. The September 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. On March 31, 2023, the principal balance due on the GS Capital September 2022 Note amounted to $195,000 and accrued interest payable amounted to $8,847. On December 31, 2022, the principal balance due on the GS Capital September 2022 Note amounted to $195,000 and accrued interest payable amounted to $5,001.
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	195000	usd
CY2022Q4	cbnt	Common Stock commonStock	112500	shares
CY2022	cbnt	Loss On Debt Extinguishment lossOnDebtExtinguishment	112500	usd
CY2021Q2	cbnt	Secured Promissory Note Amount SecuredPromissoryNoteAmount	500000	usd
CY2021Q2	cbnt	Annual Accrued Interest Percentage AnnualAccruedInterestPercentage	0.08	pure
CY2021Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.18	pure
CY2021Q3	cbnt	Capital Lease Amount CapitalLeaseAmount	95013	usd
CY2023Q1	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	30360	usd
CY2022Q4	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	39513	usd
CY2022Q4	cbnt	Received Net Proceed ReceivedNetProceed	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2023Q1	cbnt	Promissory Note Amounted PromissoryNoteAmounted	6312	usd
CY2022	cbnt	Promissory Note Amounted PromissoryNoteAmounted	2367	usd
CY2023Q1	cbnt	Principal Amount PrincipalAmount	200000	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	62323	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1477	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	1662845	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payment Due In Four And Five Years OperatingLeasesFutureMinimumPaymentDueInFourAndFiveYears	207222	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter	1870067	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	957556	usd
CY2023Q1	cbnt	Accrued Dividend Payable AccruedDividendPayable	36577	usd
CY2023Q1	us-gaap	Dividends Cash DividendsCash	8169	usd
CY2022Q1	us-gaap	Dividends Cash DividendsCash	9147	usd
CY2022	cbnt	Accrued Dividend Payable AccruedDividendPayable	74731	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	cbnt	Cash Payments CashPayments	275000	usd
CY2023Q1	cbnt	Conversion Conversion	25000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	53000	shares
CY2023Q1	cbnt	Accrued Compensations AccruedCompensations	9636364	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	14250	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0285
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12137	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	42702	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	4046	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
CY2022Q1	cbnt	Conversion Of Stock Shares Issued ConversionOfStockSharesIssued	823529	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	823529	shares
CY2022Q1	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	12963	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q1	cbnt	Voting Percentage VotingPercentage	0.10	pure
CY2023Q1	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
	cbnt	Reported Revenue ReportedRevenue	102569	usd
	cbnt	Bad Debt Expenses BadDebtExpenses	102569	usd
CY2021Q3	us-gaap	Bankruptcy Claims Amount Of Claims Settled BankruptcyClaimsAmountOfClaimsSettled	16000	usd
CY2023Q1	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2021Q1	cbnt	Bonus To Officers And Employee BonusToOfficersAndEmployee	330000	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2023Q1	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2022Q4	cbnt	Aggregate Amount AggregateAmount	160000	usd
CY2022Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	This bonus will be paid 10% in cash ($16,000) which was paid in December 2022 and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31, 2022, was included in accrued compensation on the accompanying consolidated balance sheet.
CY2023Q1	cbnt	Bonus Owed Executive Officers BonusOwedExecutiveOfficers	144000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	144	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	On May 12, 2021 and effective June 1, 2021
CY2023Q1	cbnt	Number Of Customer NumberOfCustomer	2	pure
CY2023Q1	cbnt	Customer Accounted Sales Percentage CustomerAccountedSalesPercentage	0.36	pure
CY2022Q1	cbnt	Number Of Customers NumberOfCustomers	3	pure
CY2023Q1	cbnt	Number Of Customers NumberOfCustomers	1	pure
CY2023Q1	cbnt	Concentration Risk Percentage ConcentrationRiskPercentage	0.669	pure
CY2022	cbnt	Number Of Suppliers NumberOfSuppliers	5	pure
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q1	cbnt	Revenue Revenue	515220	usd
CY2022Q1	cbnt	Revenue Revenue	510709	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20850	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22910	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	199485	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	248580	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-723087	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1919419	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	88082	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	96306	usd
CY2023Q1	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	515220	usd
CY2022Q1	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	510709	usd
	us-gaap	Payments For Rent PaymentsForRent	4444	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	5283	usd
CY2023Q1	cbnt	Lease Term LeaseTerm	P60M
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	cbnt	Lease Agreemen Description LeaseAgreemenDescription	In September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025.
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	cbnt	Lease Agreemen Description LeaseAgreemenDescription	In February 2022, the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025.
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
CY2023Q1	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	40845	usd
CY2022Q1	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	46527	usd
CY2023Q1	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2022Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	133600	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	104881	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	346693	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q1	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	348342	usd
CY2022Q4	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	376566	usd
CY2023Q1	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-120640	usd
CY2022Q4	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-117671	usd
CY2023Q1	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	227702	usd
CY2022Q4	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	258895	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	22500	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payments Due Currents OperatingLeasesFutureMinimumPaymentsDueCurrents	147956	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payments Due In Two Year OperatingLeasesFutureMinimumPaymentsDueInTwoYear	148388	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payments Due In Three Year OperatingLeasesFutureMinimumPaymentsDueInThreeYear	80934	usd
CY2023Q1	cbnt	Operating Leases Future Minimum Payments Due In Four Year OperatingLeasesFutureMinimumPaymentsDueInFourYear	22400	usd
CY2023Q1	cbnt	Total Minimum Noncancelable Operating Lease Payments TotalMinimumNoncancelableOperatingLeasePayments	399678	usd
CY2023Q1	cbnt	Discount To Fair Value DiscountToFairValue	51336	usd
CY2023Q1	cbnt	Total Lease Liability TotalLeaseLiability	348342	usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	250000	usd
CY2022Q2	cbnt	Net Proceeds NetProceeds	250000	usd
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
CY2023Q1	cbnt	Interest Expenses InterestExpenses	3699	usd
CY2023Q1	cbnt	Accruedinterest Payabless AccruedinterestPayabless	250000	usd
CY2023Q1	cbnt	Related Party Amount RelatedPartyAmount	13726	usd
CY2023Q1	cbnt	Due To Related Parties Currents DueToRelatedPartiesCurrents	250000	usd
CY2023Q1	cbnt	Accrued Interest Payable AccruedInterestPayable	10027	usd
CY2023Q1	us-gaap	Subsequent Event Effect Of Change In Tax Status SubsequentEventEffectOfChangeInTaxStatus	1989755	usd
	us-gaap	Subsequent Event Description SubsequentEventDescription	The Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable of $ $310,192 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock.
CY2022Q2	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q3	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q3	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q1	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	271825	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	271825	usd
CY2021Q2	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	875000	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	875000	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2022Q1	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent		usd
CY2022Q1	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty		usd
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
CY2022Q1	cbnt	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices		usd
CY2022Q1	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation		usd
CY2023Q1	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt		usd
CY2023Q1	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable		usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2023Q1	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife
CY2023Q1	cbnt	Goodwill Useful Life GoodwillUsefulLife
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q1	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Grants Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantsNumberOfShares		shares
CY2023Q1	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedWeightedAverageGrantDateFairValue
CY2023Q1	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedNumberOfShares		shares
CY2023Q1	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedWeightedAverageGrantDateFairValue
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
cbnt-20230331_cal.xml	Edgar Link	unprocessable
cbnt-20230331_def.xml	Edgar Link	unprocessable
0001213900-23-039843-index-headers.html	Edgar Link	pending
0001213900-23-039843-index.html	Edgar Link	pending
0001213900-23-039843.txt	Edgar Link	pending
0001213900-23-039843-xbrl.zip	Edgar Link	pending
cbnt-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_cbondsystems.htm	Edgar Link	pending
f10q0323ex31-2_cbondsystems.htm	Edgar Link	pending
f10q0323ex32-1_cbondsystems.htm	Edgar Link	pending
f10q0323_cbondsys.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
cbnt-20230331_pre.xml	Edgar Link	unprocessable
cbnt-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_cbondsys_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2023 Q2 Form 10-Q Financial Statement

#000121390023039843 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2023 Q2 Form 10-Q Financial Statement

#000121390023039843 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt